ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
GOLDMAN SACHS GROUP INC 345,485$8,827,1420.00%
STATE OF WISCONSIN INVESTMENT BOARD 19,018$485,9100.00%
STRS OHIO 21,200$5410.00%
STATE STREET CORP 1,667,925$42,615,4840.00%
Ameritas Investment Partners, Inc. 2,317$59,1990.00%
FMR LLC 940,281$24,024,1800.00%
GEODE CAPITAL MANAGEMENT, LLC 512,168$13,087,5030.00%
Allspring Global Investments Holdings, LLC 35,423$905,0570.00%
BARCLAYS PLC 112,467$2,8730.00%
PUTNAM INVESTMENTS LLC 59,845$1,529,0390.00%
BlackRock Inc. 2,137,700$54,618,2360.00%
AMERICAN INTERNATIONAL GROUP, INC. 11,637$297,3250.00%
BLAIR WILLIAM & CO/IL 18,705$477,9130.00%
MetLife Investment Management, LLC 12,327$314,9550.00%
METROPOLITAN LIFE INSURANCE CO/NY 1,394$35,6170.00%
Ameliora Wealth Management Ltd. 150$3,8320.00%
RHUMBLINE ADVISERS 36,437$930,9540.00%
Squarepoint Ops LLC 14,047$358,9010.00%
BNP PARIBAS FINANCIAL MARKETS 22,577$576,8420.00%
TWO SIGMA INVESTMENTS, LP 20,560$525,3080.00%
External links

This page lists ARCTURUS THERAPEUTICS HLDGS's shareholders in Q3 2023. To view ARCTURUS THERAPEUTICS HLDGS's shareholder history, click here.